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Abstract
Introduction: Drug resistance and metastatic spread are two of the most malicious
aspects of cancer progression. Microparticles (MPs) have previously been implicated in
the spread of these phenotypes independently. We now demonstrate that these two
characteristics are linked, with the MP-mediated acquisition of drug resistance correlating
with the emergence of an enhanced metastatic capacity. In this way, MPs serve as a
conduit between drug resistance and metastasis. Therefore, addressing the impact of
MPs may be a means of managing both of these deleterious aspects simultaneously. This
makes MPs a significant and viable target in the management of cancer.
Methods and results: We used microarray analysis to identify regulatory microRNAs
(miRNAs) contributing to the dissemination of the metastatic trait in our cancer model.
miR-503 was downregulated in recipient cells following coculture with MPs isolated from
drug resistant cells. This was inversely associated with metastatic capacity, as
demonstrated in wound healing/scratch migration assays and Matrigel®-coated transwell
invasion assays. We also found that the proline-rich tyrosine kinase 2 (PYK2) gene
transcript and miRNAs associated with its regulation, were upregulated in recipient cells
following co-culture with MPs derived from drug-resistant cells. Elevated PYK2 was
accompanied with increased migration and invasion, with these phenotypes reversible in
the presence of a pharmacological inhibitor of PYK2 phosphorylation, tyrphostin A9.
However, the MP-mediated promotion of metastatic traits was not due to the direct
transfer of effectors in the selectively packaged MP cargo. Rather, acquired PYK2 protein
and transcripts were downstream effectors of components within the cargo itself.
Therefore, the consideration of the role of MPs in trait acquisition extends beyond the
direct transfer of components within the cargo to also include the transfer of intermediary
regulators, resulting in alterations in the proteomic and transcriptional landscape of the
recipient cells. This implicates the expanding role of MPs in the deleterious survival
mechanisms of cancer pathogenesis.
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